Initial Statement of Beneficial Ownership (3)
12 Januar 2023 - 12:43AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Akdamar Erol R |
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2023
|
3. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [HCA]
|
|
(Last)
(First)
(Middle)
ONE PARK PLAZA |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Group President / |
|
(Street)
NASHVILLE, TN 37203
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 37726 | D | |
| Common Stock | 60000 | I | By LLC |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Stock Appreciation Right | (1) | 11/6/2023 | Common Stock | 9000 | $45.30 | D | |
| Stock Appreciation Right | (2) | 2/5/2024 | Common Stock | 14500 | $47.97 | D | |
| Stock Appreciation Right | (3) | 2/5/2024 | Common Stock | 12325 | $47.97 | D | |
| Stock Appreciation Right | (4) | 2/4/2025 | Common Stock | 20000 | $68.96 | D | |
| Stock Appreciation Right | (5) | 1/29/2026 | Common Stock | 16440 | $69.58 | D | |
| Stock Appreciation Right | (6) | 2/1/2027 | Common Stock | 17430 | $81.96 | D | |
| Stock Appreciation Right | (7) | 1/31/2028 | Common Stock | 25160 | $101.16 | D | |
| Stock Appreciation Right | (8) | 1/30/2029 | Common Stock | 14670 | $139.06 | D | |
| Stock Appreciation Right | (9) | 1/29/2030 | Common Stock | 16910 | $145.24 | D | |
| Stock Appreciation Right | (10) | 2/3/2031 | Common Stock | 12820 | $173.12 | D | |
| Stock Appreciation Right | (11) | 1/28/2032 | Common Stock | 8490 | $236.61 | D | |
| Explanation of Responses: |
| (1) | The stock appreciation rights vested in four equal annual installments beginning on November 6, 2014. |
| (2) | The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. |
| (3) | The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. |
| (4) | The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. |
| (5) | The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. |
| (6) | The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |
| (7) | The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |
| (8) | The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. |
| (9) | The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. |
| (10) | The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. |
| (11) | The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Akdamar Erol R
ONE PARK PLAZA
NASHVILLE, TN 37203 |
|
| Group President |
|
Signatures
|
| /s/ Kevin A. Ball, Attorney-in-Fact | | 1/11/2023 |
| **Signature of Reporting Person | Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
